Unione Europea - lettone - EMA (European Medicines Agency)

le vet b.v. - prednisolone - kortikosteroīdi sistēmiskai lietošanai, vienkāršā, prednizolons, sistēmisko hormonālo preparātu, bez pvn). dzimumhormonus un insulīnu - zirgi - iekaisuma un klīnisko parametru, kas saistīti ar recidivējošu elpceļu obstrukciju (rao), atvieglojums zirgiem kopā ar vides kontroli.

Lettonia - lettone - Zāļu valsts aģentūra

as Ņižfarm pārstāvniecība, latvija - prednizolons - ziede - 5 mg/g

Unione Europea - lettone - EMA (European Medicines Agency)

accord healthcare s.l.u. - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Unione Europea - lettone - EMA (European Medicines Agency)

mylan ireland limited - abiraterona acetāts - prostatas audzēji - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Unione Europea - lettone - EMA (European Medicines Agency)

krka, d.d., novo mesto - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Unione Europea - lettone - EMA (European Medicines Agency)

bayer ag - rādija (223ra) dihlorīds - prostatas audzēji - terapeitiskie radiofarmaceitiskie preparāti - xofigo ir indicēts pieaugušajiem ar kastrācijas rezistentu prostatas vēzi, simptomātiskas metastāzēs kauliem un nav zināma viscerālo metastāžu ārstēšanai.

Lettonia - lettone - Zāļu valsts aģentūra

pfizer europe ma eeig, united kingdom - metilprednizolons - pulveris un šķīdinātājs injekciju šķīduma pagatavošanai - 250 mg

Lettonia - lettone - Zāļu valsts aģentūra

pfizer hellas a.e., greece - metilprednizolons - pulveris un šķīdinātājs injekciju šķīduma pagatavošanai - 1000 mg

Lettonia - lettone - Zāļu valsts aģentūra

pfizer hellas a.e., greece - metilprednizolons - pulveris un šķīdinātājs injekciju šķīduma pagatavošanai - 500 mg

Lettonia - lettone - Zāļu valsts aģentūra

pfizer spol. s.r.o., czech republic - metilprednizolons - pulveris un šķīdinātājs injekciju šķīduma pagatavošanai - 40 mg